Australian Super Pty LTD Bristol Myers Squibb CO Transaction History

Australian Super Pty LTD

$19.6 Billion
Q3 2024

A detailed history of Australian Super Pty LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Australian Super Pty LTD holds 3,340,932 shares of BMY stock, worth $187 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

3,340,932

Previous 3,857,561 13.39%

Holding current value

$187 Million

Previous $160 Million 7.92%

% of portfolio

0.88%

Previous 0.94%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$39.66 - $51.75 $20.5 Million - $26.7 Million	-516,629 Reduced 13.39%	3,340,932 $173 Million
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $31.2 Million - $41.1 Million	775,908 Added 25.18%	3,857,561 $160 Million
Q1 2024 Apr 26, 2024	BUY	$47.98 - $54.4 $66.5 Million - $75.4 Million	1,386,762 Added 81.82%	3,081,653 $167 Million
Q4 2023 Jan 16, 2024	BUY	$48.48 - $57.85 $82.2 Million - $98 Million	1,694,891 New	1,694,891 $87 Million
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $815,042 - $904,976	-12,793 Reduced 33.47%	25,432 $1.63 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $75.8 Million - $85.9 Million	-1,153,158 Reduced 96.79%	38,225 $2.65 Million
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $2.05 Million - $2.43 Million	29,965 Added 2.58%	1,191,383 $85.7 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $51,730 - $30.6 Million	-397,929 Reduced 25.52%	1,161,418 $82.6 Million
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $5.16 Million - $5.68 Million	71,054 Added 4.77%	1,559,347 $120 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $20.8 Million - $25 Million	-338,678 Reduced 18.54%	1,488,293 $109 Million
Q4 2021 Jan 24, 2022	BUY	$53.63 - $62.52 $38.1 Million - $44.4 Million	710,844 Added 63.69%	1,826,971 $114 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $11.3 Million - $13.2 Million	190,988 Added 20.64%	1,116,127 $66 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $9.2 Million - $10 Million	148,594 Added 19.14%	925,139 $61.8 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $116 Million - $131 Million	-1,960,945 Reduced 71.63%	776,545 $49 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $15.8 Million - $17.9 Million	274,189 Added 11.13%	2,737,490 $170 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $75.9 Million - $84.1 Million	1,321,614 Added 115.76%	2,463,301 $149 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $28.9 Million - $33.8 Million	527,200 Added 85.8%	1,141,687 $67.1 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $14.1 Million - $20.5 Million	304,086 Added 97.97%	614,487 $34.3 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $6.43 Million - $8.38 Million	130,586 Added 72.62%	310,401 $19.9 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $7.69 Million - $9.12 Million	179,815 New	179,815 $9.12 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.

Account

Australian Super Pty LTD Bristol Myers Squibb CO Transaction History